A patient with a history of multiple cardiovascular events is prescribed clopidogrel. Which of the following pharmacogenetic factors is LEAST likely to significantly impact the efficacy of clopidogrel therapy? a) CYP2C19 genotype b) ABCB1 polymorphisms c) Vitamin K intake d) Platelet GPIIb/IIIa receptor polymorphisms
Added by Milano M.
Step 1
Clopidogrel is an antiplatelet medication that requires metabolic activation by the liver enzyme CYP2C19 to exert its therapeutic effect. It inhibits platelet aggregation by blocking the P2Y12 component of ADP receptors on the platelet surface. Show more…
Show all steps
Your feedback will help us improve your experience
Labs
Want to see this concept in action?
Explore this concept interactively to see how it behaves as you change inputs.
Key Concepts
Recommended Videos
Which are the three drug oxidation polymorphisms that have received the most clinical attention? a. CYP2D6, CYP2C9, and CYP2C19 b. CYP2D6, CYP2C9, and CYP27A1 c. CYP2D6, CYP2C9, and CYP4V2 d. CYP2D6, CYP2C9, and CYP11B2
Sanchit J.
CYP2C19 metabolizes which drugs (Select one or more of the following): * 1 point a. Dabigatran b. Coumadin c. Clopidogrel d. Apixaban
A gene that affects more than one trait is said to be a. dominant. d. pleiotropic. b. wild-type. e. heterozygous. c. dihybrid.
Recommended Textbooks
Biology for AP Courses
Objective Biology for NEET
Introduction to General, Organic and Biochemistry
Transcript
Watch the video solution with this free unlock.
EMAIL
PASSWORD